Skip to content

Clinical trials

Phase 2 Hepatitis B, Chronic trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B, Chronic Phase: Phase 2 Country / region: New Zealand Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20142
20153
20161
20171
20184
20204
20215
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated4
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences8
Assembly Biosciences6
Hoffmann-La Roche2
Vir Biotechnology, Inc.2
Aligos Therapeutics1
Arbutus Biopharma Corporation1
AusperBio Therapeutics Inc.1
Brii Biosciences Limited1
GlaxoSmithKline1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic24
Hepatitis B13
Hepatitis5
Liver Diseases2
Blood-Borne Infections1
Chronic Disease1
Communicable Diseases1
DNA Virus Infections1
Digestive System Diseases1
Disease Attributes1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.